AcylatedGLP-1analogwithahalf-lifeof160h.SemaglutideisunderevaluationforthemanagementofdiabetesII.Duetoitsprolongedhalf-life,thepeptidehastobeinjectedonlyonceperweek.

Bachemprovidesthisproductsolelyforuseswithinthescopeofanystatuteorlawprovidingforanimmunity,exemption,orexceptiontopatentinfringement(“ExemptedUses”),includingbutnotlimitedto35U.S.C.§271(e)(1)intheUnitedStates,theBolartypeexemptioninEurope,andanycorrespondingexceptiontopatentinfringementinanyothercountry.Itisthesoleresponsibilityofthepurchaseroruserofthisproduct,andthepurchaseroruserofthisproductagreestoengageonlyinsuchExemptedUses,andtocomplywithallapplicableintellectualpropertylawsand/orregulations.ThepurchaserofthisproductagreestoindemnifyBachemagainstallclaimsinconnectionwiththeperformanceoftherespectivecommercialagreement(e.g.supplyagreement)andpossIBLeinfringementsofintellectualpropertyrights.